Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.22.2.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
1 Months Ended 11 Months Ended 12 Months Ended
Dec. 31, 2021
Dec. 02, 2021
Dec. 31, 2020
Dec. 31, 2019
CONSOLIDATED STATEMENTS OF CASH FLOWS        
Financial Designation, Predecessor and Successor [Fixed List] Successor Predecessor Predecessor Predecessor
Net Loss $ (57,937,929) $ (146,399,938) $ (31,411,542) $ (41,971,558)
Adjustments to Reconcile Net Loss to Net Cash Used in Operating Activities:        
Depreciation Expense 187,558 1,540,335 795,172 399,177
Amortization of Intangible Assets 6,961,666 34,396    
Stock-Based Compensation 4,635,142 3,701,252 447,475 474,042
Amortization of Debt Origination Fees   658,587 80,237  
Amortization of Discount from Issuance of Debt   1,139,060 144,971  
Mark-to-Market Adjustment of Stock Warrants (2,271,659) 7,664,869    
Premium Deficiency Reserve 26,276,575 11,559,067 (20,539,364) 6,363,652
Changes in Assets and Liabilities, net of Acquisitions:        
Accounts Receivable 1,467,289 (1,484,932) 139,212 424,137
Health Plan Receivables / Premiums 3,236,036 (2,770,246) (27,507,240) (9,653,991)
Other Current Assets (4,704,294) 4,254,368 (4,160,078) (122,765)
Net Change in ROU Assets and Liabilities (21,886) 305,677 (704,500) (1,620,600)
Accounts Payable 7,731,972 34,224,416 8,102,668 803,503
Accrued Payroll 3,158,624 (1,134,709) 2,289,655 502,602
Accrued Interest (497,781) 5,216,440 1,848,265 2,204,141
Health Plan Payables / Premiums (2,591,997) 11,264,767 8,804,203 1,853,358
Claims Payable (971,210) 19,097,060 37,075,052 12,057,792
Net Cash Used in Operating Activities (15,341,894) (51,129,531) (24,595,814) (28,286,510)
Cash Flows From Investing Activities        
Purchases of Property, Plant and Equipment (120,559) (3,290,482) (2,926,621) (1,451,861)
Acquisitions, Net of Cash Acquired (47,879,102) (4,989,000) (130,000)  
Notes Receivable, Net 143,297 70,650 (109,527) (2,404,862)
Net Cash Used in Investing Activities (47,856,364) (8,208,832) (3,166,148) (3,856,723)
Cash Flows From Financing Activities        
Issuance (Redemption) of Class A, C and D Units     (180,000) 62,041,554
Proceeds from PIPE, Net of Issuance Costs 195,307,872      
Proceeds from Long-Term Debt, Net of Discount and Issuance Costs   24,625,000 36,433,282 16,164,914
Proceeds from Short-Term Debt 3,377,329 351,872    
Repayment of Long-Term Debt (8,008) (186,519) (1,493,221) (14,586,891)
Net Cash Provided by Financing Activities 198,677,193 24,790,353 34,760,061 63,619,577
Net Change in Cash and Restricted Cash 135,478,935 (34,548,010) 6,998,099 31,476,344
Cash and Restricted Cash at Beginning of Period 5,354,937 39,902,947 32,904,848 1,428,504
Cash and Restricted Cash at End of Period 140,833,872 5,354,937 39,902,947 32,904,848
Supplemental Cash Flow Information:        
Cash Paid for Interest $ 1,346,254 $ 2,796,368 685,419 560,246
Accrued Costs for Software (Development in Process)     $ 249,454 176,352
Conversion of Class A Units to Long-Term Debt       15,000,000
Conversion of Long-Term Debt to Class A Units       $ 3,764,245